FindTrial
Sign In

Test of an evaluation method to measure blood hemoglobin concentration without harming the body

Validation study of an evaluation method for non-invasive measurement of blood hemoglobin concentration - Validation study of an evaluation method for non-invasive measurement of blood Hb concentration

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000051091
Enrollment
50
Registered
2023-05-20
Start date
2023-05-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kao Corporation
Lead Sponsor
CPCC Company Limited
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy male and female the ages of 25 and 35

Exclusion criteria

Exclusion criteria: 1. Person who has a disease currently treatment. 2. Person who takes medications (antihypertensive, sleeping pills, antiallergic, sedatives, hormones, and other medications for illnesses). 3. Person who has thin (BMI < 18.5) or overweight (BMI > 30.0). 4. Person who has pregnant or possibly pregnant. 5. Person who currently has fever symptoms, rhinitis symptoms, or atopic symptoms. 6. Person who has ever smoked. 7. Person who has external injury to the measurement site (the ring finger of the non-dominant arm). 8. Person who deemed inappropriate by the investigator and study personnel.

Design outcomes

Primary

MeasureTime frame
-Blood hemoglobin concentration calculated by this measurement method -Blood hemoglobin concentration by colorimetric method—

Countries

Japan

Contacts

Public ContactYoshinao Nagashima

Kao Corporation Personal Health Care Products Research Lab.

nagashima.yoshinao@kao.com+81-3-5630-7486

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026